Look Under The Hood: FTKI Has 27% Upside
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 20 2025
0mins
Should l Buy CDRE?
Source: NASDAQ.COM
ETF Analysis: The First Trust Small Cap BuyWrite Income ETF (FTKI) has an implied analyst target price of $24.35 per unit, indicating a potential upside of 27.07% from its current trading price of $19.16.
Stock Performance Insights: Notable underlying holdings such as Teekay Tankers Ltd, Catalyst Pharmaceuticals Inc, and Cadre Holdings Inc show significant upside potential based on analyst targets, raising questions about the validity and optimism of these projections.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CDRE?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CDRE
Wall Street analysts forecast CDRE stock price to rise
3 Analyst Rating
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 44.000
Low
50.00
Averages
52.67
High
55.00
Current: 44.000
Low
50.00
Averages
52.67
High
55.00
About CDRE
Cadre Holdings, Inc. is engaged in the manufacturing and distribution of safety products. The Company's equipment provides protection to allow users to safely perform their duties and protect those around them in hazardous or life-threatening situations. Its core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Its principal body armor product offerings include concealable, corrections and tactical armor, which provide varying levels of protection against ballistic or sharp instrument threats. It offers an engineered portfolio of critical operator survival suits, blast sensors, accessories and vehicle blast attenuation seats for bomb safety technicians, among others. Its engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Its key brands include Safariland and Med-Eng, among others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Cadre Holdings Q4 Earnings Miss Expectations
- Disappointing Earnings: Cadre Holdings reported a Q4 GAAP EPS of $0.27, missing expectations by $0.13, with revenue of $167.2 million reflecting a 5% year-over-year decline and falling short of the anticipated $168.8 million, indicating competitive pressures in the market.
- Full-Year Sales Outlook: For fiscal year 2026, Cadre expects net sales between $736 million and $758 million, with adjusted EBITDA projected between $136 million and $141 million, suggesting a cautiously optimistic view on future growth despite not providing net income guidance due to the complexities of forecasting certain expenses and gains.
- Capital Expenditure Plans: Cadre anticipates capital expenditures in the range of $10 million to $14 million, which will be directed towards supporting long-term growth strategies, even amid revenue challenges.
- Dividend Increase: Cadre Holdings announced a 5.3% increase in its dividend to $0.10 per share, demonstrating the company's commitment to shareholder returns and aiming to bolster market confidence despite financial pressures.
See More
Cadre Holdings Reports Decline in Q4 Earnings
- Earnings Decline: Cadre Holdings reported a net income of $11.73 million for Q4, translating to an EPS of $0.27, which is a decrease from last year's $12.98 million and $0.32 per share, indicating a weakening in the company's profitability.
- Revenue Drop: The company's revenue for the fourth quarter was $167.22 million, down 5% from $175.98 million last year, reflecting weakened market demand and increased competition impacting sales.
- Performance Comparison: The decline in both earnings and revenue compared to last year suggests that Cadre Holdings is facing challenges in the current economic environment, potentially necessitating strategic adjustments to regain growth.
- Future Outlook: Despite the current underperformance, the company may need to implement measures to enhance market share and profitability, especially in a highly competitive market landscape.
See More
Cadre Holdings Secures Major Contracts Worth $86.4M
- Significant Contract Value: Cadre Holdings' unit Med-Eng has secured two contracts worth $74.6 million and $11.8 million from General Dynamics European Land Systems, indicating strong demand and market position in the military equipment sector.
- Wide Product Application: The blast attenuation seats will be deployed in the production of Mowag EAGLE V 4×4 command vehicles and EAGLE V 6×6 protected ambulance vehicles, showcasing Cadre's technological strength and market recognition in military vehicle safety.
- Production Timeline: Production and initial deliveries for the EAGLE V 4×4 program will commence in 2026 and continue through 2031, while the EAGLE V 6×6 program is scheduled from 2026 to 2029, ensuring a stable revenue stream for the company in the coming years.
- Positive Stock Reaction: Following the contract announcement, Cadre Holdings' shares rose by 1.13%, reflecting market optimism about the company's prospects and further enhancing investor confidence in its long-term growth potential.
See More
This Battlefield Defense Firm Has Embraced Nuclear Technology. It's a Clear Investment Opportunity.
Geopolitical Context: The current geopolitical instability, particularly the conflict in the Middle East, is influencing investments in the defense sector, highlighting the financial opportunities associated with war.
Cadre Holdings' Growth: For Cadre Holdings, the Middle East conflict is just one of many factors contributing to its overall growth strategy, indicating a more complex narrative beyond immediate geopolitical events.
See More
Three Key Sectors to Monitor While the S&P 500 Moves Sideways
Geopolitical Concerns: Ongoing geopolitical issues, including tensions related to Iran and international trade, are impacting market sentiment.
Tech Sector Pressures: The tech sector is facing challenges, particularly due to concerns surrounding artificial intelligence.
Investor Behavior: Instead of withdrawing from equities, investors are shifting their focus within the market.
Market Opportunities: This rotation in investment strategy is creating new pockets of opportunity for investors.
See More
U.S. Military Action Against Iran Escalates, Defense Stocks Hit Record Highs
- Defense Stocks Surge: Aerospace and defense stocks soared to record levels on Monday as escalating U.S. rhetoric towards Iran shifted market expectations towards a sustained military campaign, with the SPDR S&P Aerospace & Defense ETF (NYSE:XAR) climbing 3.6% in mid-morning trading.
- Trump's Warning: In a CNN interview, Trump hinted that the most intense phase of military action is yet to come, stating, 'We haven't even started hitting them hard,' which has heightened market concerns about future military conflicts.
- Pentagon's Statement: Defense Secretary and Joint Chiefs emphasized that the military campaign is 'not a single overnight operation,' indicating that achieving military objectives will take time and suggesting that additional forces may be deployed to the region.
- Market Demand Expectations: With over 100 aircraft involved in initial strikes, markets are pricing in sustained demand for advanced weapon systems, air defense, and surveillance technologies, reflecting an optimistic sentiment towards the defense sector.
See More
Cadre Holdings Q4 Earnings Miss Expectations
- Disappointing Earnings: Cadre Holdings reported a Q4 GAAP EPS of $0.27, missing expectations by $0.13, with revenue of $167.2 million reflecting a 5% year-over-year decline and falling short of the anticipated $168.8 million, indicating competitive pressures in the market.
- Full-Year Sales Outlook: For fiscal year 2026, Cadre expects net sales between $736 million and $758 million, with adjusted EBITDA projected between $136 million and $141 million, suggesting a cautiously optimistic view on future growth despite not providing net income guidance due to the complexities of forecasting certain expenses and gains.
- Capital Expenditure Plans: Cadre anticipates capital expenditures in the range of $10 million to $14 million, which will be directed towards supporting long-term growth strategies, even amid revenue challenges.
- Dividend Increase: Cadre Holdings announced a 5.3% increase in its dividend to $0.10 per share, demonstrating the company's commitment to shareholder returns and aiming to bolster market confidence despite financial pressures.
See More
Cadre Holdings Reports Decline in Q4 Earnings
- Earnings Decline: Cadre Holdings reported a net income of $11.73 million for Q4, translating to an EPS of $0.27, which is a decrease from last year's $12.98 million and $0.32 per share, indicating a weakening in the company's profitability.
- Revenue Drop: The company's revenue for the fourth quarter was $167.22 million, down 5% from $175.98 million last year, reflecting weakened market demand and increased competition impacting sales.
- Performance Comparison: The decline in both earnings and revenue compared to last year suggests that Cadre Holdings is facing challenges in the current economic environment, potentially necessitating strategic adjustments to regain growth.
- Future Outlook: Despite the current underperformance, the company may need to implement measures to enhance market share and profitability, especially in a highly competitive market landscape.
See More
Cadre Holdings Secures Major Contracts Worth $86.4M
- Significant Contract Value: Cadre Holdings' unit Med-Eng has secured two contracts worth $74.6 million and $11.8 million from General Dynamics European Land Systems, indicating strong demand and market position in the military equipment sector.
- Wide Product Application: The blast attenuation seats will be deployed in the production of Mowag EAGLE V 4×4 command vehicles and EAGLE V 6×6 protected ambulance vehicles, showcasing Cadre's technological strength and market recognition in military vehicle safety.
- Production Timeline: Production and initial deliveries for the EAGLE V 4×4 program will commence in 2026 and continue through 2031, while the EAGLE V 6×6 program is scheduled from 2026 to 2029, ensuring a stable revenue stream for the company in the coming years.
- Positive Stock Reaction: Following the contract announcement, Cadre Holdings' shares rose by 1.13%, reflecting market optimism about the company's prospects and further enhancing investor confidence in its long-term growth potential.
See More
This Battlefield Defense Firm Has Embraced Nuclear Technology. It's a Clear Investment Opportunity.
Geopolitical Context: The current geopolitical instability, particularly the conflict in the Middle East, is influencing investments in the defense sector, highlighting the financial opportunities associated with war.
Cadre Holdings' Growth: For Cadre Holdings, the Middle East conflict is just one of many factors contributing to its overall growth strategy, indicating a more complex narrative beyond immediate geopolitical events.
See More
Three Key Sectors to Monitor While the S&P 500 Moves Sideways
Geopolitical Concerns: Ongoing geopolitical issues, including tensions related to Iran and international trade, are impacting market sentiment.
Tech Sector Pressures: The tech sector is facing challenges, particularly due to concerns surrounding artificial intelligence.
Investor Behavior: Instead of withdrawing from equities, investors are shifting their focus within the market.
Market Opportunities: This rotation in investment strategy is creating new pockets of opportunity for investors.
See More
U.S. Military Action Against Iran Escalates, Defense Stocks Hit Record Highs
- Defense Stocks Surge: Aerospace and defense stocks soared to record levels on Monday as escalating U.S. rhetoric towards Iran shifted market expectations towards a sustained military campaign, with the SPDR S&P Aerospace & Defense ETF (NYSE:XAR) climbing 3.6% in mid-morning trading.
- Trump's Warning: In a CNN interview, Trump hinted that the most intense phase of military action is yet to come, stating, 'We haven't even started hitting them hard,' which has heightened market concerns about future military conflicts.
- Pentagon's Statement: Defense Secretary and Joint Chiefs emphasized that the military campaign is 'not a single overnight operation,' indicating that achieving military objectives will take time and suggesting that additional forces may be deployed to the region.
- Market Demand Expectations: With over 100 aircraft involved in initial strikes, markets are pricing in sustained demand for advanced weapon systems, air defense, and surveillance technologies, reflecting an optimistic sentiment towards the defense sector.
See More
